121 related articles for article (PubMed ID: 9490555)
1. [The transgenic mouse model of familial polyposis coli].
Fehmann HC; Eissele R
Z Gastroenterol; 1997 Nov; 35(11):1035-7. PubMed ID: 9490555
[No Abstract] [Full Text] [Related]
2. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
Boolbol SK; Dannenberg AJ; Chadburn A; Martucci C; Guo XJ; Ramonetti JT; Abreu-Goris M; Newmark HL; Lipkin ML; DeCosse JJ; Bertagnolli MM
Cancer Res; 1996 Jun; 56(11):2556-60. PubMed ID: 8653697
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?
Chau I; Cunningham D
N Engl J Med; 2002 Apr; 346(14):1085-7. PubMed ID: 11932478
[No Abstract] [Full Text] [Related]
4. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
Oshima M; Dinchuk JE; Kargman SL; Oshima H; Hancock B; Kwong E; Trzaskos JM; Evans JF; Taketo MM
Cell; 1996 Nov; 87(5):803-9. PubMed ID: 8945508
[TBL] [Abstract][Full Text] [Related]
5. Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case.
Esaki M; Matsumoto T; Mizuno M; Kobori Y; Yoshimura R; Yao T; Iida M
Dis Colon Rectum; 2002 Oct; 45(10):1397-402; discussion 1402-6. PubMed ID: 12394442
[TBL] [Abstract][Full Text] [Related]
6. [Familial adenomatous polyposis (FAP)--diagnosis and management].
Gondo N; Nakagawa K; Yanagi H; Yamamura T
Gan To Kagaku Ryoho; 2002 Apr; 29(4):532-8. PubMed ID: 11977536
[TBL] [Abstract][Full Text] [Related]
7. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
8. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
9. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
Buecher B; Heymann MF; Blottière HM
Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
[No Abstract] [Full Text] [Related]
10. [COX-2 associated loss of apoptosis activity in intestinal neoplams in Apc gene knock-out mice].
Schmehl K; Jacobasch G; Buhr HJ
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):479-83. PubMed ID: 14518302
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis.
Keller JJ; Offerhaus GJ; Drillenburg P; Caspers E; Musler A; Ristimäki A; Giardiello FM
Clin Cancer Res; 2001 Dec; 7(12):4000-7. PubMed ID: 11751493
[TBL] [Abstract][Full Text] [Related]
12. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
Florent C; Meary N
Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
[TBL] [Abstract][Full Text] [Related]
13. [Intestinal polyposis in APC knockout mice: mechanism of tumorigenesis and chemotherapy].
Taketo MM
Seikagaku; 1999 Nov; 71(11):1299-308. PubMed ID: 10614178
[No Abstract] [Full Text] [Related]
14. Rofecoxib (Vioxx), a specific cyclooxygenase-2 inhibitor, is chemopreventive in a mouse model of colon cancer.
Evans JF
Am J Clin Oncol; 2003 Aug; 26(4):S62-5. PubMed ID: 12902858
[TBL] [Abstract][Full Text] [Related]
15. Apc mice: models, modifiers and mutants.
McCart AE; Vickaryous NK; Silver A
Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487
[TBL] [Abstract][Full Text] [Related]
16. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
Chiu CH; McEntee MF; Whelan J
Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
[TBL] [Abstract][Full Text] [Related]
17. COX-2 inhibitors cut risk of colon polyps.
Health News; 2000 Aug; 6(8):6. PubMed ID: 10948872
[No Abstract] [Full Text] [Related]
18. The inducible prostaglandin biosynthetic enzyme, cyclooxygenase 2, is not mutated in patients with attenuated adenomatous polyposis coli.
Spirio LN; Dixon DA; Robertson J; Robertson M; Barrows J; Traer E; Burt RW; Leppert MF; White R; Prescott SM
Cancer Res; 1998 Nov; 58(21):4909-12. PubMed ID: 9809998
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice.
Sonoshita M; Takaku K; Sasaki N; Sugimoto Y; Ushikubi F; Narumiya S; Oshima M; Taketo MM
Nat Med; 2001 Sep; 7(9):1048-51. PubMed ID: 11533709
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]